Agenus to Present at Two Upcoming Healthcare Conferences
Rodman & Renshaw Global Investment Conference 2013 Stifel Nicolaus 2013 Global
LEXINGTON, Mass. -- September 4, 2013
Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and
infectious diseases, today announced that the company will present a corporate
overview at two upcoming conferences. Dr. Garo Armen, chairman and CEO of
Agenus, will present at the 15^th Annual Rodman & Renshaw Healthcare
Conference on September 10, 2013 at 10:25 am Eastern time at the Millennium
Broadway Hotel in New York City, NY. Dr. Armen will also present at the Stifel
Healthcare Conference 2013 at 10:20 am Eastern time on September 11, 2013 at
the Four Seasons Hotel in Boston, MA.
Web Cast Information
The live and archived webcast of the company presentation will be accessible
from the company’s website at www.agenusbio.com/webcast. Please log in
approximately 5-10 minutes before each event to ensure a timely connection.
The archived replay will be available on the Agenus website for one month
following the conference.
Agenus Inc. is a biotechnology company working to develop treatments for
cancers and infectious diseases. The company is focused on immunotherapeutic
products based on strong platform technologies with multiple product
candidates advancing through the clinic, including several product candidates
that have advanced into late-stage clinical trials through corporate partners.
For more information, please visit www.agenusbio.com.
Media and Investor Contact:
Jonae R. Barnes, 617-818-2985
Investor Relations and
Press spacebar to pause and continue. Press esc to stop.